MedClean Technologies Inc. CEO Publishes Letter to Sh...(ly efficiently and cost-effectively conv...),Health

Date:2/12/2009

ly, efficiently and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further information on MedClean can be found at http://www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at http://www.sec.gov.

Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business, including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2007, filed with the SEC on March 31, 2008, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

    Contacts:
    MedClean Technologies, Inc.               Investor Contact:
    Kevin Dunphy                              Cameron Donahue
    Chief Financial Officer                   Hayden IR
    (203) 798-1080                            (651) 653-1854
    kdunphy@medcleantechnologies.com          cameron@haydenir.com

'/>"/>

SOURCE MedClean Technologies, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2
Related medicine news :

1. MedClean Technologies Inc. Announces New Ticker Symbol
2. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
3. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
4. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
5. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
6. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
7. Advanced technologies aim to transform the coaching of top athletes
8. Global Med Technologies(R) Extends Its Worldwide Outreach
9. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
10. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
11. Neurobiological Technologies Reports Going Concern Qualification